• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

846
68
51
50
30

COUNTRY

30
13
13
12
12

PRICE

681
866
964
1,564

PUBLISHED

16
58
323
1,564

PRODUCT TYPE

959
499
86
16
2
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Pulmonary Tuberculosis - Pipeline Review, H2 2013

Pulmonary Tuberculosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Pulmonary Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Athlete's Foot (Tinea Pedis) - Pipeline Review, H2 2013

Athlete's Foot (Tinea Pedis) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Athlete's Foot (Tinea Pedis) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

October 2013
FROM

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2013

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2013', provides an overview of...

October 2013
FROM

Enterobacteriaceae Infections - Pipeline Review, H2 2013

Enterobacteriaceae Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Enterobacteriaceae Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

October 2013
FROM

Influenza A And B Infections - Pipeline Review, H2 2013

Influenza A And B Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza A And B Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

October 2013
FROM

Enterococcus Infections - Pipeline Review, H2 2013

Enterococcus Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Enterococcus Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2013

Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hospital Acquired Methicillin-Resistant Staphylococcus...

October 2013
FROM

Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013

Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013', provides an overview of the indication’s...

October 2013
FROM

Staphylococcal Infections - Pipeline Review, H2 2013

Staphylococcal Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Staphylococcal Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Sepsis - Pipeline Review, H2 2013

Sepsis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Sepsis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

October 2013
FROM

Escherichia Coli Infections - Pipeline Review, H2 2013

Escherichia Coli Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Escherichia Coli Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

October 2013
FROM

Gram-Positive Bacterial Infections - Pipeline Review, H2 2013

Gram-Positive Bacterial Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Gram-Positive Bacterial Infections - Pipeline Review, H2 2013', provides an overview of the indication’s...

October 2013
FROM

Rabies - Pipeline Review, H2 2013

Rabies - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Rabies - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

October 2013
FROM

H3N2 Infection - Pipeline Review, H2 2013

H3N2 Infection - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'H3N2 Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Influenza B Infections - Pipeline Review, H2 2013

Influenza B Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza B Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Lyme Disease - Pipeline Review, H2 2013

Lyme Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Lyme Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Infections Caused By Picornaviridae - Pipeline Review, H2 2013

Infections Caused By Picornaviridae - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Infections Caused By Picornaviridae - Pipeline Review, H2 2013', provides an overview of the indication’s...

October 2013
FROM

Meningococcal Meningitis - Pipeline Review, H2 2013

Meningococcal Meningitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Meningococcal Meningitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM
2014 Analysis of the Global Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies 2014 Analysis of the Global Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies - Product Thumbnail Image

2014 Analysis of the Global Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies

“2014 Analysis of the Global Infectious Disease Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the...

October 2013
FROM
2014 Analysis of the European Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies 2014 Analysis of the European Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies - Product Thumbnail Image

2014 Analysis of the European Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies

“2014 Analysis of the European Infectious Disease Testing Market” is a new five-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos